+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asthma Global Clinical Trials Review, H2, 2019

  • ID: 4629770
  • Clinical Trials
  • December 2019
  • Region: Global
  • 2349 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • AstraZeneca Plc
  • Chiesi Farmaceutici SpA
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline Plc
  • Merck & Co Inc
  • Novartis AG
  • MORE
Asthma Global Clinical Trials Review, H2, 2019

Summary

The clinical trial report, “Asthma Global Clinical Trials Review, H2, 2019“ provides an overview of Asthma clinical trials scenario. This report provides top line data relating to the clinical trials on Asthma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using the proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AstraZeneca Plc
  • Chiesi Farmaceutici SpA
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline Plc
  • Merck & Co Inc
  • Novartis AG
  • MORE
  • Report Guidance
  • Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Asthma to Respiratory Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Asthma to Respiratory Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Asthma Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Asthma
  • Nov 26, 2019: AB Science will host a live webcast on masitinib in severe asthma on December 2, 2019
  • Nov 08, 2019: Gossamer announces data presentations at the American College of Allergy, Asthma and Immunology Annual Scientific Meeting 2019
  • Nov 07, 2019: AB Science announces positive top-line Phase 3 results for oral masitinib in severe asthma
  • Oct 16, 2019: Grad student researches new drug to combat asthma
  • Oct 01, 2019: Nucala minimises exacerbations in eosinophilic asthma patients
  • Oct 01, 2019: Sosei Heptares notes the announcement of positive results from phase III IRIDIUM study of inhaled combination QVM149 in patients with uncontrolled asthma
  • Oct 01, 2019: Single-Inhaler Extrafine Triple Therapy of Inhaled Corticosteroid, Long-Acting B2-Agonist and Long-Acting Muscarinic Antagonist Therapy Improves Lung Function and Reduces Asthma Exacerbations
  • Sep 30, 2019: Novartis announces positive results from Phase III PALLADIUM study of inhaled combination QMF149 in patients with uncontrolled asthma
  • Sep 30, 2019: Novartis announces positive results from Phase III IRIDIUM study of inhaled combination QVM149 in patients with uncontrolled asthma
  • Sep 26, 2019: Pieris Pharmaceuticals and AstraZeneca present multiple ascending dose phase 1b data for inhaled IL4-Ra Antagonist AZD1402/PRS-060 at the 2019 European Respiratory Society International Congress
  • Sep 23, 2019: GlaxoSmithKline to present on Mepolizumab at ERS 2019
  • Sep 09, 2019: Theravance Biopharma reports positive results from phase 1 clinical trial of TD-8236, an investigational, lung-selective, inhaled Pan-Janus Kinase (JAK) inhibitor for inflammatory lung diseases
  • Clinical Trial Profile Snapshots
Appendix
  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About the Author
  • Contact Us
  • Source
List of Tables
  • Asthma Therapeutics, Global, Clinical Trials by Region, 2019*
  • Asthma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*
  • Asthma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019*
  • Asthma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019*
  • Asthma Therapeutics Clinical Trials, Europe, Top Five Countries, 2019*
  • Asthma Therapeutics Clinical Trials, North America, Top Countries, 2019*
  • Asthma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019*
  • Asthma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019*
  • Proportion of Asthma to Respiratory Clinical Trials, G7 Countries (%), 2019*
  • Asthma Therapeutics, G7 Countries, Clinical Trials by Phase, 2019*
  • Asthma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019*
  • Proportion of Asthma to Respiratory Clinical Trials, E7 Countries (%), 2019*
  • Asthma Therapeutics, E7 Countries, Clinical Trials by Phase, 2019*
  • Asthma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019*
  • Asthma Therapeutics, Global, Clinical Trials by Phase, 2019*
  • Asthma Therapeutics, Global, Clinical Trials In Progress by Phase 2019*
  • Asthma Therapeutics, Global, Clinical Trials by Trial Status, 2019*
  • Asthma Therapeutics Clinical Trials, Global, by End Point Status, 2019*
  • Asthma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018
  • Asthma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019*
  • Asthma Therapeutics Clinical Trials, Global, Key Sponsors, 2019*
  • Asthma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019*
  • Asthma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019*
List of Figures
  • Asthma Therapeutics, Global, Clinical Trials by Region (%), 2019*
  • Asthma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*
  • Asthma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019*
  • Asthma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019*
  • Asthma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019*
  • Asthma Therapeutics Clinical Trials, North America, Top Countries (%), 2019*
  • Asthma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019*
  • Asthma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019*
  • Proportion of Asthma to Respiratory Clinical Trials, G7 Countries (%), 2019*
  • Asthma Therapeutics, G7 Countries, Clinical Trials by Phase, 2019*
  • Asthma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019*
  • Proportion of Asthma to Respiratory Clinical Trials, E7 Countries (%), 2019*
  • Asthma Therapeutics, E7 Countries, Clinical Trials by Phase, 2019*
  • Asthma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019*
  • Asthma Therapeutics, Global, Clinical Trials by Phase (%), 2019*
  • Asthma Therapeutics, Global, Clinical Trials In Progress by Phase, 2019*
  • Asthma Therapeutics, Global, Clinical Trials by Trial Status, 2019*
  • Asthma Therapeutics Clinical Trials, Global, by End Point Status, 2019*
  • Asthma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018
  • Asthma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019*
  • Asthma Therapeutics Clinical Trials, Global, Key Sponsors, 2019*
  • Asthma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019*
  • Asthma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019*
  • Methodology
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • AstraZeneca Plc
  • GlaxoSmithKline Plc
  • Novartis AG
  • Merck & Co Inc
  • C. H. Boehringer Sohn AG & Co KG
  • Teva Pharmaceutical Industries Ltd
  • Chiesi Farmaceutici SpA
  • F. Hoffmann-La Roche Ltd
  • Pfizer Inc
  • Pamplona Capital Management LLP
Note: Product cover images may vary from those shown
Adroll
adroll